Glioblastoma multiforme surgery: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 11: | Line 11: | ||
*Surgery is used to take a section for a pathological diagnosis, to remove some of the symptoms of a large mass pressing against the brain, to remove [[tumor]] before secondary resistance to [[radiotherapy]] and [[chemotherapy]], and to prolong survival. | *Surgery is used to take a section for a pathological diagnosis, to remove some of the symptoms of a large mass pressing against the brain, to remove [[tumor]] before secondary resistance to [[radiotherapy]] and [[chemotherapy]], and to prolong survival. | ||
*Removal of 98% or more of the tumor has been associated with a better prognosis. | *Removal of 98% or more of the tumor has been associated with a better prognosis. | ||
*The chances of near-complete initial removal of the tumor can be greatly increased if the surgery is guided by a fluorescent dye known as | *The chances of near-complete initial removal of the tumor can be greatly increased if the surgery is guided by a fluorescent dye known as 5-aminolevulinic acid. | ||
*Glioblastoma multiforme tumor cells are widely infiltrative through the brain at diagnosis. Despite a near-total resection, majority of people with glioblastoma multiforme develop recurrence, either at the original site or at distant satellite lesions within the brain. | *Glioblastoma multiforme tumor cells are widely infiltrative through the brain at diagnosis. Despite a near-total resection, majority of people with glioblastoma multiforme develop recurrence, either at the original site or at distant satellite lesions within the brain. | ||
Revision as of 04:06, 20 September 2015
|
Glioblastoma multiforme Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Glioblastoma multiforme surgery On the Web |
|
American Roentgen Ray Society Images of Glioblastoma multiforme surgery |
|
Risk calculators and risk factors for Glioblastoma multiforme surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
Surgery is the mainstay of treatment for glioblastoma multiforme.[1]
Surgery
Surgery is the mainstay of treatment for glioblastoma multiforme.[1]
- An average glioblastoma multiforme tumor contains 1011 cells, which is reduced to 109 cells after surgery (a reduction of 99%).
- Surgery is used to take a section for a pathological diagnosis, to remove some of the symptoms of a large mass pressing against the brain, to remove tumor before secondary resistance to radiotherapy and chemotherapy, and to prolong survival.
- Removal of 98% or more of the tumor has been associated with a better prognosis.
- The chances of near-complete initial removal of the tumor can be greatly increased if the surgery is guided by a fluorescent dye known as 5-aminolevulinic acid.
- Glioblastoma multiforme tumor cells are widely infiltrative through the brain at diagnosis. Despite a near-total resection, majority of people with glioblastoma multiforme develop recurrence, either at the original site or at distant satellite lesions within the brain.
References
- ↑ 1.0 1.1 Treatment of glioblastoma multiforme. Dr Dylan Kurda and Dr Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/glioblastoma